journal cover

False-Positive Human Immunodeficiency Virus Type 1 Nucleic Acid Amplification Testing in Chimeric Antigen Receptor T Cell Therapy

Journal of Clinical Microbiology

Nov 6, 2019

Jocelyn R HauserY i-Wei Tang

Get paper from

Abstract

Chimeric antigen receptor (CAR) T cell immunotherapy has been a major advancement in cancer therapeutics. Reprogramming of T cells is achieved by using gammaretroviral or lentiviral vectors which may interfere with Human Immunodeficiency virus Type 1 (HIV-1) nucleic acid amplification t...read more

Mentioned in this Paper

Genome
HIV
Immunotherapy
Long Terminal Repeat
Multiple Myeloma
Nucleic Acids
T-Lymphocyte
B-Cell Lymphomas
HIV Core Protein p24
Risk Assessment
1
Paper Details
References
  • References
  • Citations
  • finger pointing at paper

    References currently unavailable

    We're still populating references for this paper, please check back later.
  • References
  • Citations
  • quote and clock

    No citations available

    This paper may not have been cited yet.

Similar Papers Found In These Feeds

Genetic Engineering to Program Cells

Genetic engineering is a process that alters the genetic structure of an organism by removing or introducing DNA. This technique is being tested to program cells. Discover the latest research on genetic engineering to program cells here.

Lymphoma, B-Cell

B-Cell Lymphoma includes types of lymphomas that affect B cells. Here is the latest research on B-Cell lymphoma.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Multiple Myeloma

Multiple Myeloma is a cancer of the plasma cells, which normally is involved in antibody production. Discover the latest research on Multiple Myeloma here.

The HIV Genome

The HIV genome is composed of two identical single-stranded RNA molecules. It contains nine genes encoding fifteen structural and regulatory viral proteins. Find the latest research on the HIV genome here.

© 2019 Meta ULC. All rights reserved

False-Positive Human Immunodeficiency Virus Type 1 Nucleic Acid Amplification Testing in Chimeric Antigen Receptor T Cell Therapy

Journal of Clinical Microbiology

Nov 6, 2019

Jocelyn R HauserY i-Wei Tang

PMID: 31694968

DOI: 10.1128/jcm.01420-19

Abstract

Chimeric antigen receptor (CAR) T cell immunotherapy has been a major advancement in cancer therapeutics. Reprogramming of T cells is achieved by using gammaretroviral or lentiviral vectors which may interfere with Human Immunodeficiency virus Type 1 (HIV-1) nucleic acid amplification t...read more

Mentioned in this Paper

Genome
HIV
Immunotherapy
Long Terminal Repeat
Multiple Myeloma
1

Related Papers

Paper Details
References
  • References
  • Citations
  • finger pointing at paper

    References currently unavailable

    We're still populating references for this paper, please check back later.
  • References
  • Citations
  • quote and clock

    No citations available

    This paper may not have been cited yet.

Get paper from

/papers/false-positive-human-immunodeficiency-virus-type/31694968